Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
7512227 | International Journal of Drug Policy | 2018 | 10 Pages |
Abstract
ROAs appear to distinctly influence health outcomes from cannabis use, yet systematic data for comparative assessments are largely lacking; these evidence gaps require filling. Especially in emerging legalization regimes, ROAs should be subject to evidence-based regulation towards improved public health outcomes. Concretely, vaporizers and edibles may offer potential for reduced health risks, especially concerning respiratory problems. Adequate cannabis product regulation (e.g., purity, labeling, THC-restrictions) is required to complement ROA-based effects.
Related Topics
Health Sciences
Medicine and Dentistry
Psychiatry and Mental Health
Authors
Cayley Russell, Sergio Rueda, Robin Room, Mark Tyndall, Benedikt Fischer,